Breakthroughs

Dr. Elizabeth McNally is a human geneticist, a Northwestern Medicine cardiologist and the director of the Center for Genetic Medicine at Northwestern. In this episode, she talks about her recent discoveries in the genetics of cardiovascular and neuromuscular disorders and shares what we can expect in the next few years in the field of genetic medicine.

For those with advanced metastatic prostate cancer, treatments are limited, but a new phase 3 international trial shows that a genetically targeted therapy could offer new hope for patients with specific gene mutations in their tumors. Northwestern's Maha Hussain, MD, recently presented the results of this landmark trial and shares her insight.

For three decades, Ali Shilatifard, PhD, has dedicated his career to revealing the causes of childhood leukemia and providing detailed molecular insight into the role of epigenetics in cancer. He hopes his discoveries will lead to a super drug that could end childhood leukemia and other cancers.

Northwestern scientists are conducting dozens of experiments and clinical trials aimed at understanding and fighting glioblastoma, the most common and aggressive primary brain tumor in adults. Rimas Lukas, MD, shares results of a promising Phase 1 clinical trial and other projects underway. 

Mozziyar Etemadi, MD, PhD, a research assistant professor in Anesthesiology and Biomedical Engineering is leading deep learning projects in his lab at Northwestern. He talks about a collaboration between Northwestern and Google that uses a deep learning system to predict lung cancer.

Every member of the Northwestern University Feinberg School of Medicine community has a voice and a perspective uniquely their own. Check out our new essay-style podcast Feinberg Perspectives, where faculty, trainees and students read pieces they’ve written themselves, using their voices to share messages, stories and insights into their lives and the field of healthcare.

In the new Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center at Northwestern, tiny bio-artificial kidneys are growing in the lab of Dr. Susan Quaggin. She and a team of scientists, with expertise in stem cells, blood vessels and developmental biology, are accelerating the development of such bioengineered organs. But that’s not all. Dr. Quaggin talks about the projects and science underway that could lead to new treatments to prevent, manage and cure kidney diseases.

Results from a randomized phase three clinical trial published in The New England Journal of Medicine could change the way women are treated for later stage endometrial cancer. Northwestern's Dr. Daniela Matei led the trial and is here with details. 

Death rates due to heart failure are increasing, especially in people under the age of 65 and specifically among Black men. What is fueling this upturn? How can it be stopped? Sadiya Khan, MD, assistant professor of medicine explains.

As we age, almost all of us have some memory loss. This age-related affliction is normal, but a new Northwestern Medicine study suggests it can be improved with non-invasive brain stimulation that sends electromagnetic pulses into a specific area of the brain. Joel Voss, PhD, an associate professor at Northwestern, led this study, published in the journal Neurology.